Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04555616 · ClinicalTrials.gov registry record · NA
Environmental Design for Behavioral Regulation in People With Dementia
A NA study, sponsored by Elizabeth K Rhodus.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT04555616: Completed NA study, sponsored by Elizabeth K Rhodus.
NCT04555616 is a NA study that has completed, run by Elizabeth K Rhodus. The registered enrollment target is 30 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04555616, a NA study, has completed, sponsored by Elizabeth K Rhodus.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
Individuals with dementia present with changes in behaviors throughout the continuum of cognitive decline. Environmental features may be influential in behavioral regulation. The purpose of this study is to assess the feasibility of environmental design protocols in older adults with dementia and their caregivers. Thirty subjects with moderate to severe Alzheimer's disease as primary dementia type, and their caregivers, will be randomly assigned to one of three arms: standard care; standard environmental design protocol; or personalized environmental design protocol.
Primary Outcome
Percentage of participants who had 75% adherence to the protocol based on visits and journals.
Interventions
- BEHAVIORAL Placebo
- BEHAVIORAL Standard Environmental Design
- BEHAVIORAL Individual Environmental Design
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2021-01-25 |
| Est. Completion | 2021-10-13 |
| Phase | NA |
What the finished NCT04555616 record still lists
NCT04555616 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT04555616 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04555616 about?
NCT04555616 is a clinical study titled "Environmental Design for Behavioral Regulation in People With Dementia". Individuals with dementia present with changes in behaviors throughout the continuum of cognitive decline. Environmental features may be influential in behavioral regulation. The purpose of this study is to assess the feasibility of environmental design protocols in older adults with dementia and th...
What is the current status of trial NCT04555616?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2021-01-25. Estimated completion is 2021-10-13.
What interventions are being tested in trial NCT04555616?
The interventions under investigation include: Placebo (BEHAVIORAL), Standard Environmental Design (BEHAVIORAL), Individual Environmental Design (BEHAVIORAL).
Who is sponsoring clinical trial NCT04555616?
This trial is sponsored by Elizabeth K Rhodus, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04555616's enrollment target sits among peer trials
30 1593rd of 2000 higher than 299 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI